Details for 2012838676

Up to date per 03.04.2026

Actions

Title / Product Name

MODIFIZIERTE NUKLEOSIDE, NUKLEOTIDE UND NUKLEINSÄUREN UND VERWENDUNGEN DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012838676

EP Publication Number

2763701

E-Number

1077965

Language

PCT Number

US12058519

Publication Date

13.08.2014 A

19.12.2018 B1

Registration Date

19.12.2018

AT Publication Date

15.01.2019

Application Date

03.10.2012

Registration Number

Priorities

03.10.2011

201161542533 P

IPC

A61K 48/00 20060101AFI20151109BHEP

Maximum Duration of Protection

03.10.2032

Owner

Moderna Therapeutics, Inc.320 Bent Street Cambridge, Massachusetts 02141US

Representative

No representatives present

Inventor

DE FOUGEROLLES, Antonin66 Summit Avenue Brookline, MA 02446US

ROY, Atanu115 Hill Street, nr. 9, Stoneham, MA 02180US

SCHRUM, Jason P.20 Watertown St., Unit 129, Watertown MA 02472-2580US

SIDDIQI, Suhaib37 University Avenue Burlington, MA 01803US

HATALA, Paul26 Monument Street, nr. 1 Charlestown, MA 02124US

BANCEL, Stephanec/o Moderna Therapeutics, Inc. 320 Bent Street Cambridge, MA 02141US